-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, WAcGUuCbm77S2VwlIfh1ebU1PxBkyLG+1H6NTLcp7LetU6h0Brc88fEXT8sJ1+iM FRgINfed04m48YL4IdUFRw== 0000897446-97-000025.txt : 19970113 0000897446-97-000025.hdr.sgml : 19970113 ACCESSION NUMBER: 0000897446-97-000025 CONFORMED SUBMISSION TYPE: SC 13G PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 19970110 SROS: NONE SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: COLLAGENEX PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001012270 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 521758016 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G SEC ACT: 1934 Act SEC FILE NUMBER: 005-47825 FILM NUMBER: 97504383 BUSINESS ADDRESS: STREET 1: 301 SOUTH STATE ST CITY: NEWTON STATE: PA ZIP: 18940 BUSINESS PHONE: 2155797388 MAIL ADDRESS: STREET 1: 301 SOUTH STATE ST CITY: NEWTON STATE: PA ZIP: 18940 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: ZESIGER CAPITAL GROUP LLC /ADV CENTRAL INDEX KEY: 0000947622 STANDARD INDUSTRIAL CLASSIFICATION: [] IRS NUMBER: 133813880 STATE OF INCORPORATION: NY FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G BUSINESS ADDRESS: STREET 1: 320 PARK AVE STREET 2: 30TH FL CITY: NEW YORK STATE: NY ZIP: 10022 BUSINESS PHONE: 2125086300 MAIL ADDRESS: STREET 1: 320 PARK AVE STREET 2: 30TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10022 FORMER COMPANY: FORMER CONFORMED NAME: ZESIGER CAPITAL GROUP LLC /ADV DATE OF NAME CHANGE: 19951109 SC 13G 1 SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No. ) CollaGenex Pharmaceuticals, Inc. (Name of Issuer) Common Stock, par value $0.01 per share (Title of Class of Securities) 19419B100 (CUSIP Number) The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be filed for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). Page 1 of 5 Pages (Continued on following page(s)) Page 2 of 5 Pages CUSIP NO. 19419B100 1. Name of Reporting Person S.S. or I.R.S. Identification No. of Above Person Zesiger Capital Group LLC Tax Id. No. 13-3813880 2. Check the Appropriate Box if a Member of a Group* (a) N/A (b) 3. SEC Use Only 4. Citizenship or Place of Organization New York, New York Number 5. Sole Voting Power 511,500 of Shares 6. Shared Voting Power N/A Beneficially Owned by Each 7. Sole Dispositive Power 629,700 Reporting Person With 8. Shared Dispositve Power N/A 9. Aggregate Amount Beneficially Owned by Each Reporting Person 629,700 10. Check Box if the Aggregate Amount in Row (9) Excludes Certain Shares* N/A 11. Percent of Class Represented by Amount in Row (9) 8.3% 12. Type of Reporting Person* Investment Adviser (IA) Page 3 of 5 Pages Item 1. (a) Name of Issuer: CollaGenex Pharmaceuticals, Inc. (b) Address of Issuer's Principal Executive Office: 301 South State Street Newtown, PA 18940 Item 2. (a), (b) and (c) Name of Persons Filing, Address of Principal Business Office and Citizenship: Zesiger Capital Group LLC 320 Park Avenue, 30th Floor New York, New York 10022 New York (d) Title of Class of Securities: Common Stock (e) CUSIP number: 19419B100 Item 3. If this statement is filed pursuant to Rule 13d-1(b), or 13d-2(b), check whether the person filing is a(n): X Investment Advisor registered under section 203 of the Investment Advisors Act of 1940 Page 4 of 5 Pages Item 4. Ownership (a) Amount Beneficially Owned 629,700 (b) Percent of Class 8.3% (c) Number of shares as to which such person has: (i) sole power to vote or to direct the vote 511,500 (ii) shared power to vote or to direct the vote N/A (iii) sole power to dispose or to direct the disposition 629,700 (iv) shared power to dispose or to direct the disposition of N/A Zesiger Capital Group ("ZCG") hereby disclaims beneficial ownership of all the above securities. Such securities are held in discretionary accounts which ZCG manages. Item 5. Ownership of Five Percent or Less of a Class. N/A Item 6. Ownership of More than Five Percent on Behalf of Another Person Clients for whom Zesiger Capital Group LLC acts as an investment adviser may withdraw dividends or the proceeds of sales from the accounts managed by Zesiger Capital Group. No single client account owns more than 5% of the class of securities. Page 5 of 5 Pages Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company N/A Item 8. Identification and Classification of Members of the Group N/A Item 9. Notice of Dissolution of Group N/A Item 10. Certification. By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired in the ordinary course of businesss and were not acquired for the purpose of and do not have the effect of changing or influencing the control of the issuer of such securities and were not acquired in connection with or as a participant in any transaction having such purpose or effect. SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. January 10, 1997 Date /s/ Barrie R. Zesiger Managing Director - Administration -----END PRIVACY-ENHANCED MESSAGE-----